Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride affects brain and blood steroids, causing lasting sexual and emotional side effects.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Stress and alcohol affect brain chemicals differently in rats, mice, and humans, influenced by genetic differences.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

Scientists identified three genes important for processing certain brain chemicals, thyroid hormones, and medications.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

A new mutation in the STS gene causes X-linked ichthyosis, even in rare female cases.

Obese women with PCOS have lower vitamin D levels.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

The effects of estrogen on human scalp hair growth are unclear and need more research.

AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

All women with significant unwanted hair growth have hormonal imbalances, often from polycystic ovary syndrome.

Testosterone therapy improved symptoms in a woman with congenital adrenal hyperplasia.

High TNF-α levels may increase hair loss risk after PRP therapy.

A thorough diagnostic process and teamwork are crucial for managing complex hyperandrogenism in postmenopausal women.

Low-dose oral minoxidil is generally safe for treating hair loss, with mostly mild side effects.

Probiotics and synbiotics may help with PCOS symptoms, but more research is needed.

A woman's severe hormone imbalance after menopause led to finding a rare ovarian tumor, treated by surgery.

Removing the ovaries can help treat hair loss caused by high androgen levels in postmenopausal women.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.